Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Heart Defects, Congenital
Interventions
DRUG

Rejuvesol

Blood transfused during surgery will be treated with Rejuvesol.

PROCEDURE

Cardiac surgery

The study interventions will take place during a routine admission for pediatric open heart surgery. The anesthetic technique for subjects undergoing cardiac surgery is standard care and the research study interventions will not change these practices in any way.

Trial Locations (1)

27710

Duke Univerisity Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER